Barry Palte

Barry Palte is an accomplished investment and business leader with extensive experience in private equity, biotechnology, and social impact ventures. Currently serving as Chairman of EQ Capital Partners, Barry focuses on delivering positive social outcomes through strategic investments aligned with UN Sustainable Development Goals. As a founding director and chairman of the audit and risk committee at GPN Vaccines, Barry is instrumental in addressing the global health challenges posed by pneumococcal disease. In addition to leadership roles at NewWave Biotech, Impact Rooms, and MustGrow Biologics Corp, Barry held the position of chief investment officer at Contour Companies, emphasizing community upliftment through real estate. Barry’s expertise is further acknowledged through participation in global initiatives such as the Horasis India Meeting and various innovation award committees. An alumnus of the University of Cape Town with first-class honors in Business Science and a fellow of the Institute of Actuaries, Barry Palte brings a robust academic and professional background to a diverse array of impactful projects and organizations.